Related Experiment Video
Updated: Jun 19, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
Prevalence and risk factors of myocardial remodeling in hemodialysis patients
Zorica Dimitrijevic1, Tatjana Cvetkovic, Miomir Stojanovic
1Clinic of Nephrology, Clinical Center Nis, Serbia.
Insights
Left ventricular hypertrophy (LVH) is common in hemodialysis (HD) patients. Mean arterial pressure, hemoglobin, IVC index, and interdialytic weight gain predict LV geometry in these individuals.
Area of Science:
- Cardiology
- Nephrology
- Medical Imaging
Background:
- Left ventricular hypertrophy (LVH) is a significant risk factor for morbidity and mortality in end-stage renal disease (ESRD) patients.
- Understanding LV geometric remodeling in hemodialysis (HD) patients is crucial for risk stratification.
Purpose of the Study:
- To determine the prevalence of abnormal left ventricular (LV) geometry in HD patients.
- To identify independent risk factors associated with LV geometric remodeling in HD patients.
Main Methods:
- Echocardiographic classification of LV geometry in 116 HD patients based on LV mass and relative wall thickness.
- Measurement of inferior vena cava (IVC) diameter and collapsibility index (CI).
- Stepwise multiple regression analysis to identify predictors of LV geometry.
Main Results:
- A high prevalence of abnormal LV geometry (92%) and LVH (81%) was observed in HD patients.
- Eccentric LVH was the most dominant geometric pattern.
- Higher mean arterial blood pressure and interdialytic weight gain, along with lower hemoglobin levels and higher IVC index, were associated with specific LV geometric patterns.
Conclusions:
- Mean arterial pressure, hemoglobin levels, IVC index, and interdialytic weight gain are independent predictors of LV geometry in HD patients.
- These factors can aid in identifying patients at higher risk for adverse cardiovascular outcomes.
Background:
Left ventricular hypertrophy (LVH) is an independent risk factor for morbidity/mortality in patients with end stage renal disease (ESRD). Our study aimed to identify prevalence as well as independent risk factors that contribute to the development of LV geometric remodeling in our HD patients.
Methods:
The left ventricles of 116 HD patients were classified echocardiographically into four different geometric patterns on the basis of LV mass and relative wall thickness. Furthermore, we measured inferior vena cava (IVC) diameter and its collapsibility index (CI) by echocardiography. Finally, we modeled a stepwise multiple regression analysis to determine the predictors of LV geometry.
Results:
Our study provides evidence that HD patients had a prevalence of abnormal LV geometry in 92% and LVH in 81%. We found all four geometric models of LV. Most dominant were eccentric LVH. Concentric LVH was observed in 37, normal geometry (NG) in 9, and concentric remodeling (CR) in 13 of HD patients. Mean arterial blood pressure was significantly higher in the cLVH group (95 +/- 10 mmHg) than in the NG and CR groups (81.6 +/- 12.3 and 80 +/- 11.8, respectively, p < 0.001). The cLVH and eCLVH groups had significantly lower mean hemoglobin (10.3 +/- 1.4 g/dL and 10.6 +/- 1g/dL, respectively) compared with the NG group (11.9 +/- 1.4 g/dL), p < 0.001. Furthermore, interdialytic weight gain (kg) was significantly higher in eCLVH group (3.13 +/- 0.8) than in NG group (2.3 +/- 1.1), p < 0.001. Mean IVC index of the eLVH group (10.83 +/- 2.07 mm/m(2)) was significantly higher than corresponding indexes of NG (10.83 +/- 2.07 mm/m(2)), CR (8.31 +/- 1.32 mm/m(2)) and cLVH (8.12 +/- 2.06 mm/m(2)) groups (p < 0.001 for each comparisons).
Conclusion:
Mean arterial pressure, hemoglobin, IVC index, and interdialytic weight gain were found to be independent predictors of LV geometry (R(2) = 0.147; p < 0.001) in HD patients.
More Related Videos
Related Concept Videos
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Hemodialysis II: Procedure and Complications
Hemodialysis III: Nursing Management
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure I: Introduction

